表紙
市場調查報告書

呼吸系統診斷的全球市場的預測 ∼2021年:各產品與服務、檢驗類型 (肺功能檢驗、影像檢查)、疾病、終端用戶

Respiratory Diagnostics Market by Product & Service (Instruments/Devices, Kits/Reagents), Test Type (Pulmonary Function Test, Imaging Test), Disease (TB, Lung Cancer, COPD), End User (Reference Laboratories, Physician Offices) - Global Forecast to 2021

出版商 MarketsandMarkets 商品編碼 396692
出版日期 內容資訊 英文 146 Pages
訂單完成後即時交付
價格
呼吸系統診斷的全球市場的預測 ∼2021年:各產品與服務、檢驗類型 (肺功能檢驗、影像檢查)、疾病、終端用戶 Respiratory Diagnostics Market by Product & Service (Instruments/Devices, Kits/Reagents), Test Type (Pulmonary Function Test, Imaging Test), Disease (TB, Lung Cancer, COPD), End User (Reference Laboratories, Physician Offices) - Global Forecast to 2021
出版日期: 2016年11月17日內容資訊: 英文 146 Pages
簡介

全球呼吸系統診斷的市場預計從2016年到2021年以7.3%的年複合成長率發展,從2016年的52億4000萬美元,成長到2021年的74億5000萬美元的規模。呼吸系統疾病的盛行率的上升和老年人口的增加,技術的進步等要素促進該市場的成長。

本報告提供全球呼吸系統診斷的市場調查,市場及診斷檢驗概要,市場成長的各種影響因素及市場機會分析,各產品&服務、檢驗類型、疾病、終端用戶、地區的趨勢與市場規模的變化與預測,競爭環境,以及主要企業的簡介等彙整。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

  • 市場概要:成果、預測
  • 各檢驗類型市場
  • 各地區市場
  • 各產品與服務市場
  • 各終端用戶市場
  • 各疾病市場

第5章 呼吸系統診斷的全球市場:概要

  • 簡介
  • 市場動態
    • 呼吸系統疾病的盛行率的上升
    • 老年人口的增加
    • 技術的進步
    • 市場成長的阻礙要素
    • 市場機會
    • 市場課題

第6章 呼吸系統診斷的全球市場:產品與服務分別分析

  • 簡介
  • 器具、設備
  • 化驗、試劑
  • 服務、軟體

第7章 呼吸系統診斷的全球市場:各檢驗類型分析

  • 簡介
  • 機械性檢驗
    • 肺功能檢驗
      • 肺量計
      • 頂峰流通量檢驗
  • 阻塞型睡眠呼吸中止症 (OSA) 診斷檢驗
  • 其他檢驗類型
  • 影像檢查
    • X光掃描
    • CT
    • MRI
    • PET
    • 其他
  • 傳統診斷檢驗
    • 免疫診斷
    • 生物化學的特徵
    • 顯微鏡
  • 分子診斷檢驗
    • PCR
    • 核酸增幅檢查
    • 原位雜合反應
    • DNA定序&次世代定序 (NGS)
    • 微陣列
    • 其他

第8章 呼吸系統診斷的全球市場:各疾病分析

  • 簡介
  • 結核
  • 氣喘
  • 肺癌
  • 慢性阻塞性肺病
  • 其他

第9章 呼吸系統診斷的全球市場:各終端用戶分析

  • 簡介
  • 醫院/臨床實驗室
  • 參考實驗室
  • 診療所
  • 其他

第10章 呼吸系統診斷的全球市場:各地區的分析

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 其他地區

第11章 競爭環境

  • 概要
  • 市場佔有率
  • 產品與服務的投入
  • 法律授權
  • 協定、聯盟、合作、合資企業、契約
  • 收購
  • 擴張

第12章 企業簡介

  • 簡介
  • PHILIPS HEALTHCARE
  • BECTON, DICKINSON & COMPANY
  • ABBOTT LABORATORIES
  • THERMO FISHER SCIENTIFIC INC.
  • BIOMERIEUX
  • ALERE INC.
  • BIO-RAD LABORATORIES, INC.
  • COSMED
  • SEEGENE INC.
  • SDI DIAGNOSTICS
    • 概要
    • 產品與服務
    • 策略
    • 發展趨勢等

第13章 附錄

目錄
Product Code: MD 4740

The global respiratory diagnostics market is projected to reach USD 7.45 billion by 2021 from USD 5.24 billion in 2016, at a CAGR of 7.3% from 2016 to 2021. Increasing prevalence of respiratory diseases, growing geriatric population, and technological advancements in respiratory diagnostic systems are the major factors driving the growth of the global respiratory diagnostics market.

Developing markets in Asia-Pacific such as Japan, China, India, South Korea, Taiwan, Australia, and Singapore offer lucrative opportunities for players in the respiratory diagnostics market. Rising geriatric population, growing per capita income, increasing investments in the healthcare industry by key market players, and expansion of private-sector hospitals to rural areas in various APAC countries are the major factors driving the growth of the respiratory diagnostics market.

The global respiratory diagnostics market is broadly segmented by product and service, test type, disease, end user, and region. On the basis of product and service, the respiratory diagnostics market is segmented into instruments & devices, assays & reagents, and software & services. The instruments and devices segment is expected to account for the largest share of the respiratory diagnostics market in 2016. This large share can be attributed to the continuous requirement of diagnostic instruments and devices in laboratories, point-of-care, and home care diagnosis.

On the basis of test type, the respiratory diagnostics market is broadly classified into mechanical tests, imaging tests, traditional diagnostic tests, and molecular diagnostic tests. In 2016, the traditional diagnostic tests segment is expected to account for the largest share of the respiratory diagnostics market. The large share of this segment can be primarily attributed to the quick turnaround time of these tests. However, over the years, advancements in technology have led to the replacement of traditional techniques with molecular diagnostic techniques.

On the basis of disease, the respiratory diagnostics market is segmented into asthma, chronic obstructive pulmonary disease, lung cancer, tuberculosis, and other diseases. The tuberculosis segment is expected to account for the largest share of the respiratory diagnostics market in 2016. The large share of this segment can be primarily attributed to the increase in tobacco smoking and growing air pollution levels.

On the basis of end user, the respiratory diagnostics market is categorized into hospital/clinical laboratories, reference laboratories, physician offices, and other end users (including blood banks, point-of-care testing, patient self-testing, home health agencies, nursing homes, and local public health laboratories). In 2016, the hospital/clinical laboratories segment is expected to account for the largest share of the global respiratory diagnostics market. Most respiratory disease diagnostics are carried out in hospitals as they are complex in nature and require technologically advanced products; this is driving the respiratory diagnostics market for hospital/clinical laboratories. Point-of-care diagnostics and patient self-testing are also expected to contribute to the growth of the respiratory diagnostics market in the forecast period due to the increasing demand for convenient testing processes and quick results.

New and innovative product launches was the dominant strategy adopted by key industry participants to increase their market share and cater to unmet needs.

Research Coverage:

From an insight perspective, this research report focuses on qualitative data, market size, and growth of various segments and subsegments, competitive landscape, and company profiles. The qualitative data covers various levels of industry analysis such as market dynamics (drivers, restraints, opportunities, and threats), winning imperatives, and burning issues. The report also offers market sizes and data on the growth of various segments in the industry. It focuses on emerging and high-growth segments, high-growth regions, and initiatives of governments. The competitive landscape covers growth strategies adopted by industry players in the last three years. The company profiles comprise basic views on key players in the respiratory diagnostics market and the product portfolios, developments, and strategies adopted by market players to maintain and increase their market shares in the near future. The abovementioned market research data, current market size, and forecast of future trends will help key players and new entrants to make the necessary decisions regarding product offerings, geographical focus, change in approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful.

Reasons to Buy the Report:

From an insight perspective, this research report focuses on various levels of analysis-industry analysis (industry trends) and company profiles, which together comprise and discuss the basic views on the competitive landscape; emerging and high-growth segments of the respiratory diagnostics market; high-growth regions; and market drivers, restraints, and opportunities.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on products offered by the top players in the respiratory diagnostics market
  • Product Development/Innovation: Detailed insights on the upcoming technologies, research & development activities, and new product launches in the respiratory diagnostics market
  • Market Development: Comprehensive information about lucrative emerging markets-the report analyzes the markets for respiratory diagnostics products across various regions
  • Market Diversification: Exhaustive information about new products, untapped geographies, and recent developments in the respiratory diagnostics market
  • Competitive Assessment: In-depth assessment of market ranking, strategies, products, and manufacturing capabilities of the leading players in the respiratory diagnostics market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. RESPIRATORY DIAGNOSTICS MARKET, BY REGION
    • 1.3.3. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. MARKET SIZE ESTIMATION
  • 2.2. MARKET BREAKDOWN AND DATA TRIANGULATION
    • 2.2.1. KEY DATA FROM SECONDARY SOURCES
    • 2.2.2. KEY DATA FROM PRIMARY SOURCES
      • 2.2.2.1. Key Industry Insights
    • 2.2.3. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

  • 3.1. CONCLUSION

4. PREMIUM INSIGHTS

  • 4.1. RESPIRATORY DIAGNOSTICS MARKET SNAPSHOT, 2016 VS. 2021
  • 4.2. RESPIRATORY DIAGNOSTICS MARKET, BY TEST TYPE
  • 4.3. RESPIRATORY DIAGNOSTICS MARKET, BY REGION
  • 4.4. RESPIRATORY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE
  • 4.5. RESPIRATORY DIAGNOSTICS MARKET, BY END USER
  • 4.6. RESPIRATORY DIAGNOSTICS MARKET, BY DISEASE

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. RISING PREVALENCE OF RESPIRATORY DISEASES
      • 5.2.1.1. High prevalence of tobacco smoking
      • 5.2.1.2. Changing lifestyles
      • 5.2.1.3. Urbanization and growing pollution levels
    • 5.2.2. RISING GERIATRIC POPULATION
    • 5.2.3. TECHNOLOGICAL ADVANCEMENTS
    • 5.2.4. MARKET RESTRAINTS
      • 5.2.4.1. Reimbursement concerns
      • 5.2.4.2. Rising healthcare costs limiting the usage of novel respiratory diagnostic techniques
    • 5.2.5. MARKET OPPORTUNITIES
      • 5.2.5.1. Growing demand for home care and point-of-care diagnostic devices
      • 5.2.5.2. High growth potential in developing Asia-Pacific countries
    • 5.2.6. MARKET CHALLENGE
      • 5.2.6.1. Lack of awareness and large underdiagnosed and undertreated population

6. RESPIRATORY DIAGNOSTICS MARKET, BY PRODUCT AND SERVICE

  • 6.1. INTRODUCTION
  • 6.2. INSTRUMENTS & DEVICES
  • 6.3. ASSAYS & REAGENTS
  • 6.4. SERVICES & SOFTWARE

7. RESPIRATORY DIAGNOSTICS MARKET, BY TEST TYPE

  • 7.1. INTRODUCTION
  • 7.2. MECHANICAL TESTS
    • 7.2.1. PULMONARY FUNCTION TESTS
      • 7.2.1.1. Spirometry
      • 7.2.1.2. Peak flow test
  • 7.3. OSA DIAGNOSTIC TESTS
  • 7.4. OTHER TEST TYPES
  • 7.5. IMAGING TESTS
    • 7.5.1. X-RAY
    • 7.5.2. COMPUTED TOMOGRAPHY
    • 7.5.3. MAGNETIC RESONANCE IMAGING (MRI)
    • 7.5.4. POSITRON EMISSION TOMOGRAPHY (PET)
    • 7.5.5. OTHER IMAGING TESTS
  • 7.6. TRADITIONAL DIAGNOSTIC TESTS
    • 7.6.1. IMMUNODIAGNOSTICS
    • 7.6.2. BIOCHEMICAL CHARACTERIZATION
    • 7.6.3. MICROSCOPY
  • 7.7. MOLECULAR DIAGNOSTIC TESTS
    • 7.7.1. PCR
    • 7.7.2. NUCLEIC ACID AMPLIFICATION TEST
    • 7.7.3. IN SITU HYBRIDIZATION
    • 7.7.4. DNA SEQUENCING & NEXT-GENERATION SEQUENCING (NGS)
    • 7.7.5. MICROARRAYS
    • 7.7.6. OTHER MOLECULAR DIAGNOSTIC TESTS

8. RESPIRATORY DIAGNOSTICS MARKET, BY DISEASE

  • 8.1. INTRODUCTION
  • 8.2. TUBERCULOSIS
  • 8.3. ASTHMA
  • 8.4. LUNG CANCER
  • 8.5. CHRONIC OBSTRUCTIVE PULMONARY DISEASE
  • 8.6. OTHER RESPIRATORY DISEASES

9. RESPIRATORY DIAGNOSTICS MARKET, BY END USER

  • 9.1. INTRODUCTION
  • 9.2. HOSPITAL/CLINICAL LABORATORIES
  • 9.3. REFERENCE LABORATORIES
  • 9.4. PHYSICIAN OFFICES
  • 9.5. OTHER END USERS

10. RESPIRATORY DIAGNOSTICS MARKET, BY REGION

  • 10.1. INTRODUCTION
  • 10.2. NORTH AMERICA
  • 10.3. EUROPE
  • 10.4. ASIA-PACIFIC
  • 10.5. REST OF THE WORLD (ROW)

11. COMPETITIVE LANDSCAPE

  • 11.1. OVERVIEW
  • 11.2. BATTLE FOR MARKET SHARE: PRODUCT & SERVICE LAUNCHES-KEY GROWTH STRATEGY ADOPTED BY MARKET PLAYERS
  • 11.3. PRODUCT & SERVICE LAUNCHES
  • 11.4. REGULATORY APPROVALS
  • 11.5. AGREEMENTS, COLLABORATIONS, PARTNERSHIPS, JOINT VENTURES, AND CONTRACTS
  • 11.6. ACQUISITIONS
  • 11.7. EXPANSIONS

12. COMPANY PROFILES (Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*

  • 12.1. INTRODUCTION
  • 12.2. PHILIPS HEALTHCARE
  • 12.3. BECTON, DICKINSON & COMPANY
  • 12.4. ABBOTT LABORATORIES
  • 12.5. THERMO FISHER SCIENTIFIC INC.
  • 12.6. BIOMERIEUX
  • 12.7. ALERE INC.
  • 12.8. BIO-RAD LABORATORIES, INC.
  • 12.9. COSMED
  • 12.10. SEEGENE INC.
  • 12.11. SDI DIAGNOSTICS

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.

13. APPENDIX

  • 13.1. INSIGHTS OF INDUSTRY EXPERTS
  • 13.2. DISCUSSION GUIDE
  • 13.3. OTHER DEVELOPMENTS
  • 13.4. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.5. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 13.6. AVAILABLE CUSTOMIZATIONS
  • 13.7. RELATED REPORTS
  • 13.8. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: TOTAL NUMBER OF DEATHS ASSOCIATED WITH RESPIRATORY DISEASES, 2000 VS. 2012
  • TABLE 2: OVERWEIGHT ADULT POPULATION STATISTICS, BY COUNTRY, 2000 VS. 2014 (% OF TOTAL ADULT POPULATION)
  • TABLE 3: GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT & SERVICE, 2014-2021 (USD MILLION)
  • TABLE 4: GLOBAL RESPIRATORY DIAGNOSTIC INSTRUMENTS & DEVICES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 5: GLOBAL RESPIRATORY DIAGNOSTIC ASSAYS & REAGENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 6: GLOBAL RESPIRATORY DIAGNOSTIC SERVICES & SOFTWARE MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 7: RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2014-2021 (USD MILLION)
  • TABLE 8: RESPIRATORY DIAGNOSTICS MARKET SIZE FOR MECHANICAL TESTS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 9: RESPIRATORY DIAGNOSTICS MARKET SIZE FOR MECHANICAL TESTS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 10: PULMONARY FUNCTION TESTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 11: SPIROMETRY TESTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 12: PEAK FLOW TESTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 13: OSA DIAGNOSTIC TESTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 14: OTHER MECHANICAL TESTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 15: RESPIRATORY DIAGNOSTICS MARKET SIZE FOR IMAGING TESTS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 16: RESPIRATORY DIAGNOSTICS MARKET SIZE FOR IMAGING TESTS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 17: X-RAY TESTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 18: CT TESTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 19: MRI TESTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 20: PET TESTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 21: OTHER IMAGING TESTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 22: RESPIRATORY DIAGNOSTICS MARKET SIZE FOR TRADITIONAL DIAGNOSTIC TESTS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 23: TRADITIONAL DIAGNOSTIC TESTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 24: IMMUNODIAGNOSTICS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 25: BIOCHEMICAL CHARACTERIZATION MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 26: MICROSCOPY MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 27: RESPIRATORY DIAGNOSTICS MARKET SIZE FOR MOLECULAR DIAGNOSTIC TESTS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 28: RESPIRATORY DIAGNOSTICS MARKET SIZE FOR MOLECULAR DIAGNOSTIC TESTS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 29: PCR TESTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 30: NUCLEIC ACID AMPLIFICATION TESTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 31: IN SITU HYBRIDIZATION TESTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 32: DNA SEQUENCING & NGS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 33: MICROARRAYS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 34: OTHER MOLECULAR DIAGNOSTIC TESTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 35: RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
  • TABLE 36: RESPIRATORY DIAGNOSTICS MARKET SIZE FOR TUBERCULOSIS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 37: RESPIRATORY DIAGNOSTICS MARKET SIZE FOR ASTHMA, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 38: RESPIRATORY DIAGNOSTICS MARKET SIZE FOR LUNG CANCER, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 39: RESPIRATORY DIAGNOSTICS MARKET SIZE FOR COPD, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 40: RESPIRATORY DIAGNOSTICS MARKET SIZE FOR OTHER DISEASES, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 41: RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 42: RESPIRATORY DIAGNOSTICS MARKET SIZE FOR HOSPITAL/CLINICAL LABORATORIES, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 43: RESPIRATORY DIAGNOSTICS MARKET SIZE FOR REFERENCE LABORATORIES, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 44: RESPIRATORY DIAGNOSTICS MARKET SIZE FOR PHYSICIAN OFFICES, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 45: RESPIRATORY DIAGNOSTICS MARKET SIZE FOR OTHER END USERS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 46: RESPIRATORY DIAGNOSTICS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 47: NORTH AMERICA: RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCTS AND SERVICES, 2014-2021 (USD MILLION)
  • TABLE 48: NORTH AMERICA: RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2014-2021 (USD MILLION)
  • TABLE 49: NORTH AMERICA: TRADITIONAL TESTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 50: NORTH AMERICA: MECHANICAL TESTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 51: NORTH AMERICA: IMAGING TESTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 52: NORTH AMERICA: MOLECULAR DIAGNOSTIC TESTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 53: NORTH AMERICA: RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
  • TABLE 54: NORTH AMERICA: RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 55: EUROPE: RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCTS AND SERVICES, 2014-2021 (USD MILLION)
  • TABLE 56: EUROPE: RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2014-2021 (USD MILLION)
  • TABLE 57: EUROPE: TRADITIONAL TESTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 58: EUROPE: MECHANICAL TESTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 59: EUROPE: IMAGING TESTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 60: EUROPE: MOLECULAR DIAGNOSTIC TESTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 61: EUROPE: RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
  • TABLE 62: EUROPE: RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 63: ASIA-PACIFIC: RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCTS AND SERVICES, 2014-2021 (USD MILLION)
  • TABLE 64: ASIA-PACIFIC: RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2014-2021 (USD MILLION)
  • TABLE 65: ASIA-PACIFIC: TRADITIONAL TESTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 66: ASIA-PACIFIC: MECHANICAL TESTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 67: ASIA-PACIFIC: IMAGING TESTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 68: ASIA-PACIFIC: MOLECULAR DIAGNOSTIC TESTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 69: ASIA-PACIFIC: RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
  • TABLE 70: ASIA-PACIFIC: RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 71: ROW: RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCTS AND SERVICES, 2014-2021 (USD MILLION)
  • TABLE 72: ROW: RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2014-2021 (USD MILLION)
  • TABLE 73: ROW: TRADITIONAL TESTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 74: ROW: MECHANICAL TESTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 75: ROW: IMAGING TESTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 76: ROW: MOLECULAR DIAGNOSTIC TESTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 77: ROW: RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
  • TABLE 78: ROW: RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 79: PRODUCT & SERVICE LAUNCHES, 2014-2016
  • TABLE 80: REGULATORY APPROVALS, 2014-2016
  • TABLE 81: AGREEMENTS, COLLABORATIONS, PARTNERSHIPS, JOINT VENTURES, AND CONTRACTS, 2014-2016
  • TABLE 82: ACQUISITIONS, 2014-2016
  • TABLE 83: EXPANSIONS, 2014-2016

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN
  • FIGURE 2: RESPIRATORY DIAGNOSTICS MARKET: TOP DOWN APPROACH
  • FIGURE 3: RESPIRATORY DIAGNOSTICS MARKET: BOTTOM UP APPROACH
  • FIGURE 4: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 5: MARKET DATA TRIANGULATION METHODOLOGY
  • FIGURE 6: RESPIRATORY DIAGNOSTICS MARKET SNAPSHOT, 2016 VS. 2021
  • FIGURE 7: RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCTS & SERVICES, 2016 VS. 2021
  • FIGURE 8: RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2016 VS. 2021
  • FIGURE 9: RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USER, 2016 VS. 2021
  • FIGURE 10: RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DISEASE, 2016 VS. 2021
  • FIGURE 11: GEOGRAPHICAL SNAPSHOT OF THE RESPIRATORY DIAGNOSTICS MARKET
  • FIGURE 12: INCREASING PREVALENCE OF RESPIRATORY DISEASES, AN IMPORTANT GROWTH DRIVER
  • FIGURE 13: MECHANICAL TESTS TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2016
  • FIGURE 14: ASIA-PACIFIC TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD
  • FIGURE 15: THE INSTRUMENTS AND DEVICES SEGMENT TO DOMINATE THE RESPIRATORY DIAGNOSTICS PRODUCTS & SERVICES MARKET IN 2016
  • FIGURE 16: HOSPITAL/CLINICAL LABORATORIES, THE LARGEST END USERS OF THE RESPIRATORY DIAGNOSTICS MARKET IN 2016
  • FIGURE 17: THE TUBERCULOSIS DISEASE SEGMENT TO DOMINATE THE RESPIRATORY DIAGNOSTICS DISEASE MARKET IN 2016
  • FIGURE 18: RESPIRATORY DIAGNOSTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 19: COPD AND ASTHMA PREVALENCE, BY COUNTRY, 2014
  • FIGURE 20: SMOKING PREVALENCE, BY COUNTRY, 2010 (% OF TOTAL POPULATION)
  • FIGURE 21: GLOBAL GERIATRIC POPULATION, BY REGION
  • FIGURE 22: INSTRUMENTS & DEVICES TO DOMINATE THE RESPIRATORY DIAGNOSTICS MARKET IN 2016
  • FIGURE 23: TRADITIONAL DIAGNOSTIC TESTS TO DOMINATE THE RESPIRATORY DIAGNOSTICS MARKET DURING THE FORECAST PERIOD
  • FIGURE 24: TUBERCULOSIS SEGMENT TO DOMINATE THE RESPIRATORY DIAGNOSTICS MARKET IN 2016
  • FIGURE 25: HOSPITAL/CLINICAL LABORATORIES TO DOMINATE THE RESPIRATORY DIAGNOSTICS MARKET IN 2016
  • FIGURE 26: ASIA-PACIFIC MARKET PROJECTED TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD
  • FIGURE 27: NORTH AMERICA: RESPIRATORY DIAGNOSTICS MARKET SNAPSHOT
  • FIGURE 28: INSTRUMENTS/DEVICES SEGMENT TO DOMINATE THE RESPIRATORY DIAGNOSTIC PRODUCTS AND SERVICES MARKET IN NORTH AMERICA
  • FIGURE 29: ASIA-PACIFIC: RESPIRATORY DIAGNOSTICS MARKET SNAPSHOT
  • FIGURE 30: COMPANIES MAJORLY PURSUED THE STRATEGY OF PRODUCT & SERVICE LAUNCHES BETWEEN 2014 AND 2016
  • FIGURE 31: GEOGRAPHIC REVENUE MIX OF THE TOP FIVE MARKET PLAYERS
  • FIGURE 32: COMPANY SNAPSHOT: PHILIPS HEALTHCARE
  • FIGURE 33: COMPANY SNAPSHOT: BECTON, DICKINSON AND COMPANY
  • FIGURE 34: COMPANY SNAPSHOT: ABBOTT LABORATORIES
  • FIGURE 35: COMPANY SNAPSHOT: THERMO FISHER SCIENTIFIC INC.
  • FIGURE 36: COMPANY SNAPSHOT: BIOMERIEUX
  • FIGURE 37: COMPANY SNAPSHOT: ALERE INC.
  • FIGURE 38: COMPANY SNAPSHOT: BIO-RAD LABORATORIES, INC.
  • FIGURE 39: COMPANY SNAPSHOT: SEEGENE INC.